澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

RADIOPHARM THERANOSTICS LTD

0.022

0.000

成交量：161.66萬

成交額：3.56萬

市值：7,797.28萬

市盈率：-1.19

高：0.023

開：0.022

低：0.022

收：0.022

52周最高：0.040

52周最低：0.017

股本：35.44億

流通股本：28.56億

量比：2.41

換手率：0.06%

股息：- -

股息率：- -

每股收益(TTM):-0.018

每股收益(LYR):-0.018

淨資產收益率：-109.20%

總資產收益率：-27.70%

市淨率：1.74

市盈率(LYR):-1.19

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

RADIOPHARM THERANOSTICS LTD可能會不定期發行及銷售最高可達5000萬美元的股票- SEC文件

RADIOPHARM THERANOSTICS LTD：在RAD 101二期B期腦轉移成像試驗中，92%的患者達到主要終點

Radiopharm Theranostics獲批准啓動RAD 402（Klk3-Mab與Tb161）在晚期前列腺癌中的一項I期治療試驗

Radiopharm Theranostics宣佈RAD101影像在腦轉移瘤的二期臨牀試驗招募達到50%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RAD.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"RAD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RAD.AU\",,,,,undefined,":{"symbol":"RAD.AU","market":"AU","secType":"STK","nameCN":"RADIOPHARM THERANOSTICS LTD","latestPrice":0.022,"timestamp":1770684776891,"preClose":0.022,"halted":0,"volume":1616587,"delay":0,"changeRate":0,"nameEN":"RADIOPHARM THERANOSTICS LTD","floatShares":2856071021,"shares":3544216000,"eps":-0.018424,"marketStatus":"交易中","change":0,"latestTime":"02-10 11:54:27 AEDT","open":0.022,"high":0.023,"low":0.022,"amount":35602,"amplitude":0.045455,"askPrice":0.023,"askSize":1539521,"bidPrice":0.022,"bidSize":814730,"shortable":3,"etf":0,"ttmEps":-0.018424,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1770699600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.022,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":2.405128,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RAD.AU\",,,,,undefined,":{"symbol":"RAD.AU","floatShares":2856071021,"roa":"-27.70%","roe":"-109.20%","lyrEps":-0.018424,"volumeRatio":2.405128,"shares":3544216000,"dividePrice":0,"high":0.023,"amplitude":0.045455,"preClose":0.022,"low":0.022,"week52Low":0.017,"pbRate":"1.74","psRate":"6.23","week52High":0.04,"institutionHeld":0,"latestPrice":0.022,"committee":-0.307865,"eps":-0.018424,"divideRate":0,"volume":1616587,"delay":0,"ttmEps":-0.018424,"open":0.022,"prevYearClose":0.025,"prevWeekClose":0.021,"prevMonthClose":0.021,"prevQuarterClose":0.025,"fiveDayClose":0.023,"twentyDayClose":0.024,"sixtyDayClose":0.024,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAD.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAD.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1193463844","title":"RADIOPHARM THERANOSTICS LTD可能會不定期發行及銷售最高可達5000萬美元的股票- SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1193463844","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193463844?lang=zh_tw&edition=fundamental","pubTime":"2025-12-17 06:14","pubTimestamp":1765923253,"startTime":"0","endTime":"0","summary":"RADIOPHARM THERANOSTICS LTD可能会不定期发行及销售最高可达5000万美元的股票- SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAD.AU","BK7067"],"gpt_icon":0},{"id":"1159923558","title":"RADIOPHARM THERANOSTICS LTD：在RAD 101二期B期腦轉移成像試驗中，92%的患者達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=1159923558","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159923558?lang=zh_tw&edition=fundamental","pubTime":"2025-12-15 20:08","pubTimestamp":1765800493,"startTime":"0","endTime":"0","summary":"RADIOPHARM THERANOSTICS LTD：在RAD 101二期B期脑转移成像试验中，92%的患者达到主要终点","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","RAD.AU"],"gpt_icon":0},{"id":"1132004040","title":"Radiopharm Theranostics獲批准啓動RAD 402（Klk3-Mab與Tb161）在晚期前列腺癌中的一項I期治療試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1132004040","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132004040?lang=zh_tw&edition=fundamental","pubTime":"2025-11-18 19:12","pubTimestamp":1763464332,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics获批准启动RAD 402（Klk3-Mab与Tb161）在晚期前列腺癌中的一项I期治疗试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","RAD.AU"],"gpt_icon":0},{"id":"1177466463","title":"Radiopharm Theranostics宣佈RAD101影像在腦轉移瘤的二期臨牀試驗招募達到50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1177466463","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177466463?lang=zh_tw&edition=fundamental","pubTime":"2025-11-17 21:02","pubTimestamp":1763384530,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics宣布RAD101影像在脑转移瘤的二期临床试验招募达到50%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAD.AU","BK7067"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RAD.AU\",params:#limit:6,delay:true,,,undefined,":[]}}